Ambu Q2 2020/21 Results Investor Presentation

Ambu presents Q2 2020/21 financial results and strategic updates on single-use endoscopy expansion. The company announced 6% total company growth with 20% organic growth in H1, alongside plans to introduce 20 new products over three years and expand manufacturing capacity in Mexico and R&D in Germany.